10-Q quarterly report · filed Oct 30, 2026

BrightSpring Health Services, Inc. (BTSG) Q3 2026 10-Q Quarterly Report

Short answer

BrightSpring Health Services, Inc. (BTSG) filed its Q3 2026 10-Q quarterly report on Oct 30, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $4.2B (up 26.4% year over year) with net income of $100M.

Q3 2026 key financials · XBRL

Revenue
$4.2B
+26.4% YoY · +8.8% QoQ
Net income
$100M
+79.3% YoY · +18.8% QoQ
Operating margin
3.8%
Gross margin
12.3%
EPS (diluted)
$0.46
+84.0% YoY · +21.1% QoQ

Source: XBRL data from the BrightSpring Health Services, Inc. (BTSG) Q3 2026 10-Q on SEC EDGAR. USD.

BrightSpring Health Services, Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $4,213.2M, up $879.1M or 26.4% YoY
  • Gross margin 12.3% vs 11.8% YoY, operating margin 3.8% vs 2.6%
  • Best segment: Pharmacy Solutions revenue $3,732.4M, up 25.8%; EBITDA $202.0M, up 43.3%
  • Worst product line: Home and Community Pharmacy revenue $552.6M, down $37.4M or 6.3%
  • Cash $717.8M, operating cash flow $371.2M; $300.0M debt repayment and $120.0M share repurchases disclosed

Risk Factors

  • Healthcare regulatory and compliance risk: 2025 10-K risk factors remain unchanged
  • Operational risk: Business disruption risks carried forward from the 2025 10-K
  • Financial risk: Financial-condition risks carried forward from the 2025 10-K
  • Unknown-risk exposure: Unidentified or currently immaterial risks could materially harm results

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other BrightSpring Health Services, Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.